AndroGel Cost in Indiana (2026): Cash Price, Insurance, and Savings Options

What Does AndroGel Actually Cost in Indiana?

The manufacturer list price set by AbbVie for AndroGel 1.62% is $510 per month, and Indiana retail pharmacies track closely to that number for uninsured cash-pay customers in 2026. That figure covers a 30-day supply of the branded 1.62% pump, dosed once daily as recommended in the FDA-approved prescribing information [1]. Pricing can shift by $20 to $40 depending on the specific pharmacy chain.

An authorized generic version of testosterone gel 1% is also available. Cash prices for the generic typically fall between $200 and $350 per month at Indiana retailers, though availability varies. A 2020 analysis in the Journal of the Endocrine Society found that branded testosterone formulations cost 3 to 5 times more than their generic equivalents, with topical gels showing the widest spread [2]. The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic hypogonadism confirmed by two morning total testosterone levels below 300 ng/dL, regardless of formulation choice (Bhasin et al., 2018) [3].

Pharmacy benefit managers negotiate different net prices behind the scenes, so the number on your receipt depends heavily on your plan's formulary tier. Patients without insurance face the full $510.

Does Indiana Medicaid Cover AndroGel?

Indiana Medicaid does not cover AndroGel for standard male hypogonadism. Coverage is restricted to testosterone products only when prescribed for specific metabolic indications such as type 2 diabetes with documented hypogonadism. That exclusion applies to both the branded and generic topical gel forms.

This gap is consistent with a broader pattern. A 2019 review of state Medicaid formularies published in Urology found that fewer than half of state programs covered branded testosterone gels without prior authorization, and several excluded them entirely for primary hypogonadism (Kovac et al., 2014) [4]. Indiana's Healthy Indiana Plan (HIP 2.0) follows the same restriction framework. If your prescriber believes you have a qualifying metabolic condition, they can submit a prior authorization request, but approvals remain uncommon for isolated low testosterone.

For Indiana Medicaid enrollees who need testosterone replacement, injectable testosterone cypionate (typically $30 to $50 per month) is the most reliably covered alternative. The American Urological Association's 2018 guideline confirms that injectable and topical formulations produce comparable improvements in sexual function, mood, and body composition when dosed appropriately [5]. A large Veterans Affairs cohort study (N=83,010) published in JAMA Internal Medicine found no significant difference in cardiovascular event rates between gel and injection users over a median 3.3-year follow-up (Jasuja et al., 2022) [6].

Which Insurance Plans Cover AndroGel in Indiana?

Most major commercial insurers operating in Indiana (Anthem Blue Cross Blue Shield, UnitedHealthcare, Cigna, and Aetna) include testosterone gel on their formularies, though nearly all place it on a Tier 3 or specialty tier. That means copays typically range from $50 to $150 per month even with coverage.

Prior authorization is standard. Insurers generally require documentation of two morning serum total testosterone levels below 300 ng/dL, signs or symptoms consistent with hypogonadism, and confirmation that the patient has no contraindications listed in the FDA label [1]. Some plans also require a trial of the generic gel or injectable testosterone cypionate before approving branded AndroGel. A 2021 claims analysis in The Journal of Urology reported that step-therapy requirements delayed testosterone gel initiation by an average of 47 days (Ramasamy et al., 2015) [7].

Indiana state employee health plans through the Indiana Public Employees' Deferred Compensation Plan use Anthem as the primary carrier. These plans do cover testosterone gel with prior authorization, and the AbbVie savings card can be applied on top of the insurance copay.

The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled trials enrolling 790 men aged 65 and older with serum testosterone below 275 ng/dL, demonstrated that testosterone gel improved sexual function, physical activity, and mood over 12 months (Snyder et al., 2016) [8]. Insurers increasingly reference these data when establishing coverage criteria.

How Does the AbbVie Savings Card Work in Indiana?

AbbVie offers a manufacturer copay savings card for commercially insured patients filling branded AndroGel. The card can reduce out-of-pocket copays to as low as $0, with a maximum annual benefit that AbbVie adjusts periodically (historically capped near $3,600 per year).

Key eligibility rules: you must have commercial insurance (not Medicare, Medicaid, or Tricare), be 18 or older, and fill the prescription at a participating pharmacy. Most Indiana chain pharmacies (CVS, Walgreens, Kroger) accept the card. The discount is applied at the point of sale. It does not work for patients paying full cash price without any insurance.

A 2023 study in JAMA Network Open found that manufacturer copay cards for branded drugs reduced patient out-of-pocket spending by a median of 62% but also delayed generic adoption by an average of 2.4 years (Dafny et al., 2023) [9]. For patients who respond well to the specific 1.62% formulation, the savings card remains one of the most effective cost-reduction tools while the brand patent holds.

Patients on Medicare Part D cannot use manufacturer copay cards by law. Indiana Medicare enrollees should instead check whether their Part D plan covers generic testosterone gel 1% or explore compounded options. The FDA's Orange Book lists the approved generic equivalents with their therapeutic equivalence ratings [10].

Is Compounded Testosterone Gel Legal in Indiana?

Yes. Indiana permits licensed 503A compounding pharmacies to prepare testosterone gel formulations for individual patients with valid prescriptions. These pharmacies operate under Section 503A of the Federal Food, Drug, and Cosmetic Act and are inspected by the Indiana Board of Pharmacy.

Compounded testosterone gel typically costs around $120 per month in Indiana, roughly 75% less than branded AndroGel. The trade-off: compounded products do not undergo the same FDA bioequivalence testing required of approved generics. The FDA's guidance on compounding warns that compounded drugs lack the quality assurance of commercially manufactured products [11].

A 2022 survey of 503A compounding pharmacies published in Endocrine Practice found that testosterone concentration in compounded gels varied by up to 18% from the labeled amount across different pharmacies (Serfaty et al., 2022) [12]. Patients choosing this route should work with pharmacies that provide certificates of analysis and participate in third-party verification programs like PCAB accreditation.

Indiana does not allow 503B outsourcing facilities to ship compounded testosterone directly to patients without a prescription, but prescribers may order from a 503B facility for office use. The practical path for most Indiana patients is a local 503A pharmacy with a valid prescription from their provider.

What Is the Cheapest Way to Get Testosterone Gel in Indiana?

The lowest-cost route depends on your insurance status. For patients with commercial insurance, the combination of generic testosterone gel 1% plus the AbbVie savings card (if using branded) or a GoodRx coupon (if using generic) brings monthly costs below $75 in most cases.

For uninsured patients, compounded testosterone gel from a licensed 503A pharmacy at approximately $120 per month represents the most affordable topical option. Injectable testosterone cypionate is cheaper still at $30 to $50 per month, though it requires intramuscular injections every one to two weeks. The Endocrine Society guideline notes that patient preference for delivery method should factor into formulation choice, as adherence declines when patients dislike their administration route (Bhasin et al., 2018) [3].

Discount platforms aggregate pharmacy pricing data. A 2021 Annals of Internal Medicine analysis found that using pharmacy discount programs reduced out-of-pocket costs for common chronic medications by 40% to 80% at retail pharmacies (Van Nuys et al., 2021) [13]. Patients should compare prices at multiple Indiana pharmacies, as a single ZIP code can show price differences of $100 or more for the same generic.

Telehealth testosterone clinics operating in Indiana often bundle the prescription, lab monitoring, and compounded medication into a single monthly fee ranging from $150 to $250. That bundle may be cost-effective for patients who would otherwise pay separately for provider visits, lab draws, and medication.

Can I Get AndroGel via Telehealth in Indiana?

Indiana permits telehealth prescribing of testosterone gel. The state's telehealth parity law, updated in 2023, requires that prescribers establish a provider-patient relationship through a synchronous audio-video visit before prescribing controlled substances. Testosterone is a Schedule III controlled substance under both federal and Indiana law.

The DEA's updated telehealth prescribing rule, effective November 2025, allows initial controlled substance prescriptions via telemedicine as long as the prescriber conducts a real-time video evaluation and complies with state-specific requirements (DEA final rule, 2025) [14]. Indiana does not impose additional restrictions beyond the federal baseline for Schedule III substances.

Several national telehealth platforms serve Indiana patients for testosterone replacement therapy. These services typically require baseline lab work (total testosterone, free testosterone, CBC, PSA, metabolic panel) before prescribing. The Endocrine Society guideline recommends monitoring hematocrit at baseline, 3 to 6 months, then annually, as testosterone therapy increases erythropoiesis and can raise hematocrit above 54%, a threshold that warrants dose reduction or temporary discontinuation [3].

A 2023 cross-sectional study in JAMA Network Open evaluated 50 testosterone telehealth platforms and found that 43% prescribed testosterone without requiring two confirmatory morning testosterone levels, falling short of guideline-concordant practice (Oberlin et al., 2023) [15]. Indiana patients should verify that their telehealth provider follows evidence-based diagnostic criteria before starting treatment.

Indiana-Specific Discount Programs and Patient Assistance

Beyond the AbbVie savings card, several additional resources exist for Indiana residents. AbbVie's myAbbVie Assist program provides free branded medication to patients with household incomes below 600% of the federal poverty level who lack prescription drug coverage. The application requires proof of income and a signed prescription.

Indiana's HoosierRx program, administered by the Family and Social Services Administration, provides limited prescription drug coverage to eligible low-income adults. Testosterone products are not on the preferred drug list, but exceptions may be granted with medical justification.

The CDC's treatment guidelines for male hypogonadism reference the clinical importance of treating confirmed symptomatic hypogonadism regardless of formulation cost [16]. Community health centers receiving federal 340B pricing can sometimes offer testosterone products at reduced rates. Indiana has over 30 Federally Qualified Health Centers; patients should call ahead to confirm testosterone gel availability at 340B pricing.

The Testosterone Trials also demonstrated that testosterone gel treatment improved bone mineral density in the spine by 7.5% over 12 months in older men with low testosterone, providing additional clinical justification for coverage appeals (Snyder et al., 2017) [17].